Dr. Joseph Merriman, MD

  • Chattanooga, TN
  • Hematologist and oncologist
NPI1669714226PAC ID8022238161
Medicare services, 2024
34,918
Medicare patients, 2024
513
Part D claims, 2024
662
MIPS score, 2024
93
Hospital affiliations
2
Practice address
605 Glenwood Dr, Chattanooga, TN 37404
Practice phone
Call (615) 329-0570
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Tennessee Oncology

Chattanooga, Tennessee

See all 7 affiliations

Find Dr. Merriman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Joseph Merriman is a hematologist and oncologist in Chattanooga, Tennessee

Dr. Merriman practices at Tennessee Oncology in Chattanooga, Tennessee.

Dr. Merriman's NPI, 1669714226, was assigned on March 21, 2013. Dr. Merriman holds North Carolina license 2019-00651.

NPI and contact details
Medicare PAC ID
8022238161
NPI enumeration date
March 21, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(615) 329-0570
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
39
Medical school graduation
2013

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Joseph Merriman practices at Tennessee Oncology in Chattanooga, Tennessee

Dr. Merriman's primary practice is Tennessee Oncology, at 605 Glenwood Dr, Chattanooga, TN 37404 in Hamilton County. The practice phone is (615) 329-0570.

  • Tennessee Oncology
    605 Glenwood Dr, Chattanooga, TN 37404 · Hamilton CountyPhone(615) 329-0570

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Joseph Merriman is affiliated with 5 sites of care and 2 medical groups

Dr. Merriman's primary practice is Tennessee Oncology in Chattanooga, Tennessee. Dr. Merriman is also affiliated with Ascension Saint Thomas Hospital West. The medical group on file is Tennessee Oncology. Dmand AI also links Dr. Merriman to 1 more hospital, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

See all 7 affiliations for Dr. Merriman

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Joseph Merriman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merriman practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Tennessee OncologyAvailable with a free account
+4 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Merriman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Joseph Merriman is one of 271 hematologists and oncologists in Tennessee

Hematology and oncology is Dr. Merriman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Merriman's licenses on file in 2 states: North Carolina and Tennessee.

Specialties and state licenses

  • Hematology and oncology, North CarolinaPrimaryLicense 2019-00651 · taxonomy 207RH0003X
  • Internal medicine, TennesseeLicense MD0000055851 · taxonomy 207R00000X

Hematologists and oncologists near Dr. Merriman

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Joseph Merriman billed Medicare for 34,918 services in 2024

CMS data shows 34,918 Medicare services from Dr. Merriman across 51 procedure codes in 2024, for 513 Medicare patients. Medicare paid $873,395 for them. Every service was in an office.

Medicare services, 202434,918
Medicare patients513
Paid by Medicare$873,395
Procedure codes51

Dr. Merriman's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 31,9592024: 30,2755%
Lab and pathology
2023: 1,3292024: 2,28872%
Tests and treatments
2023: 6172024: 94753%
Surgery
2023: 3622024: 59765%
Office and hospital visits
2023: 4332024: 51519%
Other services
2023: 02024: 296

Dr. Merriman compared with the Tennessee median for hematologists and oncologists, 2024

  • Dr. Merriman
  • Tennessee median
Medicare services
34,918vs 81842.7 times
Medicare patients
513vs 28779% above
Part D claims
476vs 5086% below

Medians across 259 hematologists and oncologists in Tennessee with Dmand AI profiles that report each measure.

Dr. Merriman's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Merriman

Need commercial claims for Dr. Merriman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Merriman and other hematologists and oncologists in Tennessee.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Joseph Merriman treated 513 Medicare patients in 2024, average age 75

CMS counts 513 Medicare patients who saw Dr. Merriman in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Merriman's median patient age at 64, with 63% women.

Medicare patients, 2024513
Average age75
Average risk score1.82
Also on Medicaid10%

Dr. Merriman's Medicare patients by age, 2024

Dr. Merriman's Medicare patients by sex, 2024

  • Women32463%
  • Men18937%

Chronic conditions among Dr. Merriman's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis51%
  4. Cancer42%
  5. Chronic kidney disease41%
  6. Diabetes35%
  7. Ischemic heart disease35%
  8. Anxiety32%

Share of Medicare patients with each condition. A patient can have several.

Dr. Merriman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 64

Patient panel by sex, all payers

  • Women63%
  • Men37%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Joseph Merriman wrote 662 Medicare Part D claims in 2024

In 2024, Dr. Merriman wrote 662 Medicare Part D claims for 137 patients. 72% of them were for generic drugs. CMS names the drug for 476 of them, across 18 drugs with 11 or more claims each, at $810,993 in total drug cost. In 2023, CMS named 305 claims across 18 drugs.

Part D claims, 2024662
Drugs named by CMS18
Total drug cost$810,993
Part D patients137

Dr. Merriman's Part D claims by kind of drug, 2024

  • Generic478 claims72%
  • Brand-name184 claims28%

Dr. Merriman's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Merriman's Part D claims, 2024

  • Opioids6%39 of 662 claims
  • Antibiotics2%11 of 662 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3052024: 47656%

Drugs named by CMS: 18 in 2024, 18 in 2023.

See all prescribing by Dr. Merriman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Joseph Merriman scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Merriman for performance year 2024, reported as part of a group. Dr. Merriman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Merriman's MIPS scores, performance year 2024

  • 93of 100Final score
  • 89of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Merriman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Joseph Merriman received $50,526 in industry payments from 2016 to 2025

CMS Open Payments shows 191 general payments to Dr. Merriman from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. AstraZeneca Pharmaceuticals LP paid the most, $21,496.

General payments to Dr. Merriman by program year, 2016 to 2025

General payments to Dr. Merriman by kind, 2016 to 2025

$50.5Kin total
  • Speaker and faculty fees$35,30070%
  • Consulting fees$9,41919%
  • Food and beverage$5,21910%
  • Entertainment$2180%
  • Other$3701%

Companies that paid Dr. Merriman the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Merriman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Joseph Merriman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Joseph Merriman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Joseph Merriman's NPI number?

Dr. Joseph Merriman's NPI number is 1669714226. It was assigned on March 21, 2013, and it is active in the NPI Registry.

What kind of doctor is Dr. Joseph Merriman?

Dr. Joseph Merriman is a hematologist and oncologist in Chattanooga, Tennessee. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Joseph Merriman practice?

Dr. Merriman practices at 605 Glenwood Dr, Chattanooga, TN 37404. Dr. Merriman's primary practice is Tennessee Oncology in Chattanooga, Tennessee. Dmand AI also links Dr. Merriman to 1 hospital, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group.

What is Dr. Joseph Merriman's office phone number?

The practice phone on file for Dr. Merriman is (615) 329-0570.

What is Dr. Joseph Merriman's medical license number?

Dr. Merriman holds North Carolina license 2019-00651, one of the licenses on file in 2 states.

Which states has Dr. Joseph Merriman been licensed in?

Dmand AI has state licenses on file for Dr. Merriman in North Carolina and Tennessee.

Which hospitals is Dr. Joseph Merriman affiliated with?

Dr. Merriman is affiliated with Ascension Saint Thomas Hospital West. Dmand AI links Dr. Merriman to 1 more hospital.

What medical group is Dr. Joseph Merriman part of?

Dr. Merriman is linked to Tennessee Oncology. Dmand AI links Dr. Merriman to 1 more medical group.

Does Dr. Joseph Merriman accept Medicare?

Yes. CMS data shows Dr. Merriman billed Medicare for 34,918 services in 2024, and Dr. Merriman accepts Medicare assignment.

What is Dr. Joseph Merriman's MIPS score?

Dr. Merriman's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.

Show 5 more questionsShow fewer questions

How many Medicare patients does Dr. Joseph Merriman see?

CMS counts 513 Medicare patients who saw Dr. Merriman in 2024, with an average age of 75.

What services does Dr. Joseph Merriman bill to Medicare?

In 2024, Dr. Merriman's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J0881) and injected or infused drug (J9267).

What drugs does Dr. Joseph Merriman prescribe most?

In 2024 Medicare Part D data, Dr. Merriman's most prescribed drugs by claims were Eliquis, Lidocaine-Prilocaine and Ondansetron HCl.

Has Dr. Joseph Merriman received payments from drug or device companies?

CMS Open Payments shows $50,526 in general payments to Dr. Merriman from 37 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Joseph Merriman been practicing?

Dr. Merriman graduated from medical school in 2013, 13 years ago.

Selling to hematology and oncology practices?

See hematologists and oncologists in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)